Bio-Imaging Technologies Market to Reach US$ 17.60 Billion by 2031 | CAGR 15.3% | Key Players: GE Healthcare, Abbott Laboratories, Hitachi Medical, Bayer AG, Esaote S.p.A, Clario, Digirad, Bracco

Market Overview

The Global Bio-imaging Technologies Market reached US$ 5.94 billion in 2023 and is projected to reach US$ 17.60 billion by 2031, growing at a CAGR of 15.3% during 2024-2031. Bio-imaging technologies enable non-invasive visualization of biological processes, allowing researchers, clinicians, and pharmaceutical developers to observe live cellular and molecular events with minimal interference. These technologies provide critical 3D structural information and functional insights for applications in drug discovery, diagnostics, genomics, and medical research.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/bio-imaging-technologies-market?Juli

Recent Key Developments:

✅ May 2025: Evident Co. Ltd. (Japan) launched the IXplore IX85 SpinXL and SpinSR spinning disk confocal microscopes, featuring high‐speed imaging and super‐resolution capabilities for live‐cell and 3D biological analysis, enhancing precision and throughput for research applications.

✅ 2025: Quanterix Corporation completed the acquisition of Akoya Biosciences Inc., integrating advanced bioimaging platforms for protein biomarker detection and expanding its capabilities in oncology, neurology, and immunology research workflows.

✅ Late 2025: MBF Bioscience's SLICETM light‐sheet microscope was recognized for innovation, democratizing high‐performance 3D imaging and enabling advanced spatial analyses of cleared biological samples.

✅ Latest 2025: LICORbio introduced the AtlasTM Imaging System, a high‐speed platform capable of rapid 2D and whole‐sample 3D imaging with multiple optical channels, accelerating deep spatial insights with fewer imaging steps.

✅ 2024-2025: GE HealthCare rolled out its Freelium sealed magnet MRI platform, which uses significantly less helium than traditional MRI systems and supports more sustainable, accessible imaging operations in healthcare settings.

Key Players:
GE Healthcare, Abbott Laboratories, Hitachi Medical Corporation, Bayer AG, Esaote S.p.A, Clario, Digirad Corporation, Bracco, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Hologic Inc and FONAR Corporation.

Buy Now & Unlock 360° Market Intelligence:-https://www.datamintelligence.com/buy-now-page?report=bio-imaging-technologies-market?Juli

Regional Insights:

North America: 38% - The largest share of the bio‐imaging technologies market is held in North America, supported by high healthcare expenditure, strong adoption of advanced imaging systems in hospitals and research institutions, and active pharmaceutical and biotech sectors. The United States leads regionally due to extensive clinical research infrastructure, rapid uptake of novel imaging modalities, and a well‐established reimbursement ecosystem.

Europe: 25% - Europe maintains a significant market presence, driven by widespread use of bio‐imaging technologies in clinical diagnostics, academic research, and pharmaceutical development. Countries such as Germany, the United Kingdom, and France have strong imaging device adoption rates, supported by favorable government policies for healthcare innovation and funding for life sciences research.

Asia Pacific: 28% - The Asia Pacific region is the fastest‐growing market, fueled by increasing healthcare investment, rising incidence of chronic diseases, expanding research activities, and growing demand for high‐performance imaging systems in countries like China, India, Japan, and South Korea. Rapid expansion of diagnostic facilities and increasing pharmaceutical R&D drive adoption of both clinical and preclinical bio‐imaging solutions.

Market Dynamics:

Drivers:

The global bio-imaging technologies market is primarily driven by the rising prevalence of chronic disorders, increasing research and development (R&D) investments, and rapid technological advancements. Growing adoption of bio-imaging technologies for the diagnosis, prevention, and treatment of diseases such as cancer, neurodegenerative disorders, and cardiovascular conditions is fueling market growth. The increasing incidence of carcinomas worldwide has further accelerated demand, prompting healthcare companies to invest heavily in R&D and introduce novel imaging products.

Innovations and product launches are significantly contributing to market expansion. For example, Abbott's Ultreon Software-powered optical coherence tomography (OCT) platform received FDA clearance in August 2022, integrating artificial intelligence with OCT to provide detailed visualization of coronary blood flow and blockages, thereby enhancing clinical decision-making. Such developments highlight the trend toward advanced imaging systems that improve diagnostic accuracy and patient outcomes.

Speak to Our Analyst and Get Customization in the report as per your requirements:-https://www.datamintelligence.com/customize/bio-imaging-technologies-market?Juli

Market Segmentation:

By Technology Type:
The Radiological imaging segment holds the largest share of approximately 32% of the global bio-imaging technologies market, driven by widespread use in diagnostic imaging and advanced CT systems. Magnetic Resonance Imaging (MRI) follows with around 25%, supported by increasing adoption in neuroimaging and cancer diagnosis. Optical imaging and Ultrasound imaging account for roughly 18% and 12%, respectively, owing to their non-invasive nature and real-time imaging capabilities. Nano-Bio Imaging is an emerging segment, contributing about 8%, while other imaging technologies make up the remaining 5%, reflecting specialized or hybrid imaging modalities.

By Application:
The Medical Bio-Imaging application dominates the market with approximately 70% share, reflecting high demand for diagnostic imaging in hospitals, clinics, and research centers. Molecular Bio-Imaging accounts for around 30%, driven by growth in preclinical research, drug development, and personalized medicine applications.

By End-User:
Hospitals are the primary end-users, representing about 65% of the market due to large-scale adoption of multi-modality imaging systems and continuous investment in healthcare infrastructure. Diagnostic centers account for the remaining 35%, with their share rising as outpatient imaging and specialized testing centers expand, particularly in urban regions and emerging economies.

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?Juli

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.